SPOTLIGHT: AstraZeneca buys Canadian facility


AstraZeneca has beefed up its biotech side with the purchase of Royal DSM's biologics manufacturing facility in Canada. AstraZeneca plans to use the 66,000-square-foot site to make antibodies for clinical testing. Report